• Latest Posts
Podcast 6 Oct 2023

Beyond Biotech podcast 66 – treating rare diseases with tRNA

Roche and Alnylam to work on RNAi therapeutic to treat hypertension

ADVERTISEMENT

Korro Bio and Frequency Therapeutics to merge

In Depth 10 Jul 2023

“Ready-to-use” enzymatically produced cell-free synthetic DNA in mRNA manufacturing

Flamingo Therapeutics receives €1.7M to advance RNA-targeting oncology portfolio

FDA approval for Rznomics’ glioblastoma treatment trial

SiSaf siRNA therapy gets FDA designations to treat autosomal dominant osteopetrosis

Exothera partners with Quantoom and launches DNA business unit

ADVERTISEMENT